[go: up one dir, main page]

NO147601C - Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse l-pyroglutamyl-l-histidyl-glycin - Google Patents

Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse l-pyroglutamyl-l-histidyl-glycin

Info

Publication number
NO147601C
NO147601C NO783027A NO783027A NO147601C NO 147601 C NO147601 C NO 147601C NO 783027 A NO783027 A NO 783027A NO 783027 A NO783027 A NO 783027A NO 147601 C NO147601 C NO 147601C
Authority
NO
Norway
Prior art keywords
pyroglutamyl
glycin
histidyl
preparing
active compound
Prior art date
Application number
NO783027A
Other languages
English (en)
Other versions
NO783027L (no
NO147601B (no
Inventor
Karl-Ludwig Reichelt
Olav Edvardt Trygstad
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Publication of NO783027L publication Critical patent/NO783027L/no
Publication of NO147601B publication Critical patent/NO147601B/no
Publication of NO147601C publication Critical patent/NO147601C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO783027A 1977-09-06 1978-09-05 Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse l-pyroglutamyl-l-histidyl-glycin NO147601C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3719377 1977-09-06

Publications (3)

Publication Number Publication Date
NO783027L NO783027L (no) 1979-03-07
NO147601B NO147601B (no) 1983-01-31
NO147601C true NO147601C (no) 1983-05-11

Family

ID=10394541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO783027A NO147601C (no) 1977-09-06 1978-09-05 Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse l-pyroglutamyl-l-histidyl-glycin

Country Status (12)

Country Link
EP (1) EP0001174B1 (no)
JP (1) JPS5951935B2 (no)
AT (1) AT363624B (no)
AU (1) AU518157B2 (no)
CA (1) CA1105926A (no)
DE (1) DE2860944D1 (no)
DK (1) DK390678A (no)
ES (1) ES473090A1 (no)
FI (1) FI64349C (no)
IT (1) IT1106283B (no)
NO (1) NO147601C (no)
ZA (1) ZA785022B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
JPS59188235U (ja) * 1983-06-01 1984-12-13 東レ株式会社 建築用下見板
US4719207A (en) * 1984-06-25 1988-01-12 Yamanouchi Pharmaceutical Co., Ltd. CNS active substituted azetidinone compounds
US4785003A (en) * 1984-10-16 1988-11-15 Biomeasure, Inc. N-disubstituted glycine and B-amino-propionic acid derivatives having anti-ulcer activity
US4598067A (en) * 1984-10-16 1986-07-01 Biomeasure, Inc. Antiulcer compounds
DE3876448T2 (de) * 1987-09-17 1993-04-08 Hafslund Nycomed As Verwendung eines tripeptids zur herstellung einer pharmazeutischen zusammensetzung sowie eine pharmazeutische zusammensetzung und methode.

Also Published As

Publication number Publication date
AT363624B (de) 1981-08-25
EP0001174B1 (en) 1981-08-12
ZA785022B (en) 1979-10-31
FI64349C (fi) 1983-11-10
IT1106283B (it) 1985-11-11
DE2860944D1 (en) 1981-11-12
ATA642878A (de) 1981-01-15
AU3955478A (en) 1980-03-13
FI64349B (fi) 1983-07-29
IT7850967A0 (it) 1978-09-05
CA1105926A (en) 1981-07-28
JPS5488267A (en) 1979-07-13
NO783027L (no) 1979-03-07
AU518157B2 (en) 1981-09-17
JPS5951935B2 (ja) 1984-12-17
NO147601B (no) 1983-01-31
ES473090A1 (es) 1979-10-16
DK390678A (da) 1979-03-07
FI782714A (fi) 1979-03-07
EP0001174A1 (en) 1979-03-21

Similar Documents

Publication Publication Date Title
NO145657C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater.
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO149035C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
NO152049C (no) Analogifremgangsmaate for fremstilling av den farmasoeytisk anvendelige forbindelse 4,5,6,7-tetrahydroisoksazolo (5,4-c)pyridin-3-ol
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO150203C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive 4-hydroksy-2h-1,2-benzotiazin-3-karboksamid-1,1-dioksyder
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO780883L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO151288C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolokinolizindiner
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO145793C (no) Analogifremgangsmaate for fremstilling av den fysiologisk aktive forbindelse n-(r-tetrahydrofurfuryl)-noroksymorfon
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO147601C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse l-pyroglutamyl-l-histidyl-glycin
NO149314C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner
NO147483C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner.
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO151861C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-substituert-10,11-dihydro-5h-dibenzo-(a,d)-cyclohepten-5,10-iminer
NO146776C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridobenzodiazepiner
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO145135C (no) Analogifremgangsmaate ved fremstilling av den terapeutisk aktive forbindelse 3-cyan-n-(n,n-diemtylaminopropyl)-iminodibenzyl